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A Townsend PetersonAbstract
Virus taxonomy at present is best characterized as a categorization of convenience, without a firm basis in the
principles of evolutionary biology. Specifically, virus species definitions appear to depend more on tradition and
popular opinion among virologists than on firm, quantitative biological evidence. I suggest a series of changes to
underlying species concepts that would shift the field from one that simply files viruses away in taxonomic boxes
to one that can learn important biological lessons from its taxonomy.Introduction
The International Code of Virus Classification and
Nomenclature defines a species as “a monophyletic group
of viruses whose properties can be distinguished from
those of other species by multiple criteria” cix [1]. The
Code has undergone several large-scale changes in recent
years that improve it and make it more comprehensive
and authoritative as a basis for virus taxonomy [1]; the
emphasis on monophyly now brings viral species much
more in line with those recognized in other major groups
(animals, plants). Nonetheless, how the very general defin-
ition offered in the Code translates into species-level tax-
onomies of viruses still has several shortcomings that limit
seriously its utility in understanding viral diversity.What do we want from a species-level classification?
Most biological classifications aim to achieve three goals:
organization, stability, and predictivity. The first two goals
are shared with the virus Code: obviously, we require a
classification that allows efficient organization of our
understanding of virus diversity, and this classification
should be as stable and immune to wild change as pos-
sible, to avoid introducing confusion in the scientific lit-
erature. The third goal, however, is more complex and
challenging, and at the same time potentially rewarding: a
solid biological classification would offer predictive power
about the characteristics of near relatives of known species
(see example in [2]).
The Code’s requirement that members of different spe-
cies taxa be distinguishable by multiple criteria indicates
that decisions regarding species status should not basedCorrespondence: town@ku.edu
Biodiversity Institute, University of Kansas, Lawrence, KS 66045, USA
© 2014 Peterson; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.on a single criterion (e.g., considering host association,
symptoms caused in host, genetic distance, and other fac-
tors). In some sense, this idea makes sense, as it implies
that species will not be recognized based on trivial variation
in single sets of characters. However, it is also on this point
that the Code begins to go awry. That is, one criterion and
one criterion alone should indeed dominate: evolutionary
independence of evolving lineages [3].
Full summary of viral diversity will also appreciate the
potentially diverse ways in which viruses may evolve,
which will be obscured by such multiple criteria for spe-
cies recognition. If a particular lineage differentiates gen-
etically, but retains the same host and causes the same
effects in hosts, for example, that combination of diver-
sity and non-diversity is a very interesting feature of that
lineage; if such lineages were ignored in viral taxonomy,
as would occur under this ‘multiple criterion’ definition
in the Code, this phenomenon would be missed and its
potential in contributing to viral evolution and innovation
would go unappreciated. On the other hand, a single
lineage that jumps easily among multiple hosts and causes
diverse effects, nonetheless, is not likely to diversify appre-
ciably and may have substantial gene flow among different
host populations, and we would have no basis for consid-
ering it as multiple species.
My point is that defining species is, by nature, a state-
ment about evolutionary history and how it has structured
viral diversity into species taxa. Demanding that species
be monophyletic is a first step, but distinguishing species
by multiple criteria, if some are nonevolutionary in nature
(e.g., host in which occurrence was detected, geographic
range, symptomatology), does not aid in appreciating the
true phylogenetic diversity of viruses. Other questions fall
in realms outside of systematics and taxonomy: e.g., host. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and symptomatology is a question for public health or
molecular biology of disease. An ideal species-level tax-
onomy, rather, will reflect evolutionary history, and spe-
cies limits should be based on evolutionary independence
of lineages.
Examples
Reviewing recent taxonomic summaries of several virus
families points to some degree of variation in concepts
and protocols. Some virus groups appear to be at such
early stages of discovery as to lack a taxonomy, such as
the Transfusion Transmitted Virus (TTV) and related vi-
ruses, where a recent paper stated that “… a precise and
unambiguous naming of the various species listed should
be performed” [4], although knowledge of that group ap-
pears very scanty. For members of the family Geminiviri-
dae, recent taxonomic treatments use a criterion of <89%
sequence identity for a virus to be assigned to a separate
species [5-7], now with some standardization of methods
for calculating sequence identity via decisions about how
to treat gap characters [5]; see discussion of sequence
identity metrics below. Decisions regarding species status
of candidate viruses in these groups, then, appear simply
to hinge on levels of sequence divergence in relation to an
arbitrary numerical criterion.
An example with considerably more thought and infor-
mation available is the case of ebola and marburg viruses,
family Filoviridae, which aptly illustrates the complexities
of the situation and the problems that the current system
causes, thanks to a detailed recent treatment by the Inter-
national Committee on Taxonomy of Viruses (ICTV) Filo-
viridae Study Group [8]. The diagnoses of members of
each of the species of the family (which in formal tax-
onomy constitutes the set of qualities that defines mem-
bership in the species in question) comprise three pieces
of information, none of which, in the end, proves particu-
larly satisfactory as a species diagnosis. First is a statement
of where the species is endemic… for example, for Sudan
ebolavirus, the statement is “being endemic in the Repub-
lic of Sudan and the Republic of Uganda.” Note, however,
that geographic range is an epiphenomenon of the species,
and is not an evolved characteristic of the species—if some
traveler were to export this virus unwittingly to, say,
Beijing, would the helpful filovirus taxonomist reply, “no,
can’t be Sudan ebolavirus, because China is not within the
diagnosis of the species”? This issue of geographic range
being a nonevolved phenomenon of a species is well-
known in other sectors of biology, where invasive species
are a common example of range expansions that do not
necessarily involve evolutionary change [9].
The second characteristic listed for each of the species
is number of gene overlaps. Here again, no useful, diagnos-
tic information is provided. The Reston ebolavirus genomehas two gene overlaps (VP35/VP40, VP24/L), whereas Taï
Forest ebolavirus, Sudan ebolavirus, and Bundibugyo ebo-
lavirus are diagnosed as sharing the same two overlaps,
plus one more (GP/VP30); however, Zaire ebolavirus can
show either two or three overlaps [8]. Finally, the genus
Marburgvirus is stated as having only one gene overlap,
but which one is not specified in the formal diagnosis,
such that one ends up unsure of the exact characteristics
of the genus; at least within Ebolavirus, no diagnostic
character appears to exist.
Finally, each virus is characterized in terms of sequence
differentiation. For example, for species in Ebolavirus, the
criterion is stated as ≥30% different from the type se-
quence of the genus, but <30% different from the type
sequence of whichever species is in question. This meas-
ure of genetic differentiation is at least a measure of affin-
ity, but the criterion of 30% sequence differentiation
(compared with 29% or 31%) is entirely arbitrary, and has
no special meaning to the biology, evolution, or any other
characteristic of the virus in question.
The end result is curious. Geographic range is a nonge-
netic epiphenomenon unrelated to the identity of the virus,
and no diagnostic differences exist in number or identity
of gene overlaps, so sequence differentiation is the only
characteristic that more or less diagnoses these virus
species. In the end, then, filovirus taxonomy devolves
into a single-character diagnosis, contra statements in
the Code, but a single character that is arbitrary in na-
ture because it does not consider the context of genetic
differentiation among viruses within the lineage.
The problem in filoviruses becomes even more acute
in Marburgvirus. The recent, detailed taxonomic treat-
ment of the family [8] included a section titled, “Marburg
virus and Ravn virus are distinct viruses that are members
of the same species,” which justifies treating the genus as
monospecific. The statement
… five lineages of marburgviruses are currently
recognized. The genomes of representative
marburgvirus variants of one of these lineages differs
from all others by up to 21.3% in nucleotide sequence,
whereas the genomes of variants from the other four
lineages differ from each other only by as much as
0.0–7.8%.
is followed by diagnoses that go as follows: “diverging in
genomic nucleotide sequence from the type variant of the
type virus of the species Marburg marburgvirus (Musoke)
by ≤ 10%” versus “diverging in genomic nucleotide se-
quence from the type variant of the type virus of the
species Marburg marburgvirus (Musoke) by ≥ 10% but
different from the type variant of Ravn virus by ≤ 10%.”
That is, Ravn virus is ~20% distinct from the type virus
of the genus, which is less than 30% but more than 10%,
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species. Why 30% and why 10%? What do these num-
bers tell us, if anything? Why 10% and not 11%, other
than the roundness of the number?
The difference between the ICTV arrangement and
the lineage-independence result would probably be only
one species (Ravn) in the filoviruses; Peterson and Holder
[10] demonstrated lineage independence of Ravn from the
remaining known Marburg viruses. Under the ICTV ar-
rangement, the very distinct and lineage-independent
Ravn is given the same rank as viruses that have no separ-
ate evolutionary history or biological origins, creating a
taxonomy that tells us little about the diversity of the virus
family. What is lost is a key insight: under the ICTV view,
Marburgvirus comprises a single species with a broad geo-
graphic range, but under the lineage-independence view,
Marburgvirus comprises two species that are broadly sym-
patric. These differences have important implications for
understanding and anticipating host associations for these
viruses [11-13].
Conclusions: how should the viral code change?
If the goal of taxonomy is to organize biological diversity
so as to maximize organization, stability, and predictivity,
it is clear that biological criteria must come to dominate
the process. We can only hope that viral taxonomy will
see the end of Article 3 Rule I-3.3, which states that “…
decisions on questions of taxonomy and nomenclature
should reflect the majority view of the appropriate viro-
logical constituency.” Such decisions should not be a popu-
larity vote, but rather should be based on explicit biological
criteria see early example in [14]. I applaud several recent
positive steps, though, such as emphasis on monophyly,
and linking unique ‘type genomic sequences’ with ap-
proved names of individual virus species [15].
Viral taxonomy can change positively by, simply put,
bringing in basic principles of evolutionary biology.
Virologists have made considerable progress in distin-
guishing ‘viruses’ (i.e., individual isolates or strains), but
higher-level taxa (such as species) can say much of im-
portance about viral diversity. That is, a species-level
taxonomy should be viewed as a statement of the diver-
sity that has evolved over the history of a group. Two
immediate corollaries are evident, both as regards deci-
sions about species status.
First, a frequent statement against recognition of a virus
species is that it still shows antigenic cross-reactivity with
other (recognized) lineages (similar statements are made
about host associations or symptomatology, although these
characteristics are not necessarily evolved features of the
virus). The fallacy of this argument was pointed out de-
cades ago in animal systematics, as regards the relevancy
of reproductive compatibility of animal species in setting
species limits [3]: antigenic cross-reactivity is an ancestral(plesiomorphous) trait of the broader lineage that gave rise
to the two forms in question. The fact that they have not
yet evolved antigenic non-cross-reactivity does not say
that they have not evolved significantly and independently
in other regards, to the point that they merit species sta-
tus. Rather, use of such plesiomorphic traits in recognizing
species (or not) is equivalent to lumping all rodents into a
single species because they all have hair and mammary
glands. A more positive approach is to assume that the two
candidate forms are the same species until proof emerges
of independent evolution in the two lineages, such as fixing
derived (apomorphic) traits in each lineage—these traits
could include fixing sufficient numbers of bases in a
gene sequence, or any other evolved, derived feature of
the virus.
Second, species limits can and should be established
quantitatively based on estimates of lineage independence,
which in essence depend on measures of genetic diversity
between lineages relative to genetic diversity within line-
ages. That is, a criterion of 30% sequence differentiation
means little if within-lineage diversity reaches 29.9%.
Molecular systematists working with vertebrates have
developed a series of approaches to determining lineage
independence [16-20] that take into account variation
and differentiation both within and between lineages, al-
though the specifics of these criteria should depend on
the specific evolutionary mechanisms that dominate in
a particular group [3]; these approaches can be adapted
to evolutionary mechanisms of viruses [indeed, ref [10]
prototyped such an analysis of the Marburg-Ravn situ-
ation, and found that the two lineages are clearly evolv-
ing independently]. A first step is to use appropriate
evolutionary model-based measures of evolutionary di-
vergence, as the simple sequence difference currently
being employed do not take into account multiple sub-
stitutions [21]: what was a bad idea for vertebrates [22],
where interspecific divergences are well below 10%, is a
really bad idea for viruses, where divergences are com-
monly much deeper, with much more opportunity for
multiple substitutions. A much better idea would be to
appeal to coalescent approaches that can consider his-
torical and present population sizes in deriving much
more meaningful measures of evolutionary divergence
[23]. This general focus on virus species as evolving lin-
eages would be a healthy change for the field of viral
systematics.
A final point is that this commentary is a view from
the outside, and I am sure that it will be received as such
by many in the community: an unwanted intrusion into
the business of others. Indeed, a number of virus-specific
points should be considered carefully: e.g., (1) very rapid
and often massively varying rates of evolution and the
confusions that can result, (2) large-scale propensity of vi-
ruses for reassortment or recombination, and (3) the large
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not yet available (which should be designated as incertae
sedis). Nonetheless, more generally, it is clear that virus
taxonomy is failing in a number of regards. Viewing virus
diversity as the present-day snapshot of a wide array of
evolving lineages would not change the picture drastically,
but would change the picture of current virus diversity in
ways that may not be expected. Most importantly, defini-
tions of species-level entities in the virus world would be
based on evolutionary concepts, rather than a mixture of
evolutionary and nonevolutionary concepts and criteria.Acknowledgments
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